MannKind Corporation

MannKind Corporation
TypePublic
Nasdaq: MNKD
Russell 2000 Component
IndustryBiotechnology
Founded1991 (1991)
FounderAlfred E. Mann
Headquarters,
U.S.
Key peopleKent Kresa (chairman)
Dr. Michael E. Castagna (CEO)
RevenueIncreaseUS$63.038 million (2019)
Negative increase −US$44.597 million (2019)
Negative increase −US$51.903 million (2019)
Total assetsDecrease$93.725 million (2019)
Total equityIncrease$284.252 million (2019)
Number of employees
Decrease 233 (2019)
Websitemannkindcorp.com

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.

MannKind Corporation was named after its founder, Alfred E. Mann.